These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
    Author: Putnam CW, Bell RH, Beart RW, Anderson JT, Weil R.
    Journal: Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847.
    Abstract:
    We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantation since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.
    [Abstract] [Full Text] [Related] [New Search]